about
Intracellular events and cell fate in filovirus infectionInhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomesRole of activating transcription factor 3 (ATF3) in endoplasmic reticulum (ER) stress-induced sensitization of p53-deficient human colon cancer cells to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis throughHistone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIPEVER2 protein binds TRADD to promote TNF-α-induced apoptosisDeath receptor 6 induces apoptosis not through type I or type II pathways, but via a unique mitochondria-dependent pathway by interacting with Bax proteinSmall molecules, big effects: the role of microRNAs in regulation of cardiomyocyte deathImprinted and X-linked non-coding RNAs as potential regulators of human placental functionCell death pathways and autophagy in the central nervous system and its involvement in neurodegeneration, immunity and central nervous system infection: to die or not to die--that is the questionStructure-Guided Rescaffolding of Selective Antagonists of BCL-X LCell apoptosis, autophagy and necroptosis in osteosarcoma treatmentIntegrative analysis of kinase networks in TRAIL-induced apoptosis provides a source of potential targets for combination therapyTRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathwaysTrailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer CellsIdebenone and resveratrol extend lifespan and improve motor function of HtrA2 knockout miceSTL-based analysis of TRAIL-induced apoptosis challenges the notion of type I/type II cell line classificationSoluble tumor necrosis factor related apoptosis inducing ligand level as a predictor of severity of sepsis and the risk of mortality in septic patientsGene Expression Ratios Lead to Accurate and Translatable Predictors of DR5 Agonism across Multiple Tumor LineagesEmodin suppresses hyperglycemia-induced proliferation and fibronectin expression in mesangial cells via inhibiting cFLIPA novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous routeParadoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cellsModulating cell-to-cell variability and sensitivity to death ligands by co-drugging.Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin).Novel Lignan and stilbenoid mixture shows anticarcinogenic efficacy in preclinical PC-3M-luc2 prostate cancer model.Enhancement of TRAIL-induced apoptosis by 5-fluorouracil requires activating Bax and p53 pathways in TRAIL-resistant lung cancers.PPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy fluxEffective TRAIL-based immunotherapy requires both plasmacytoid and CD8α dendritic cells.Hedgehog inhibition promotes a switch from Type II to Type I cell death receptor signaling in cancer cellsF-box protein 10, an NF-κB-dependent anti-apoptotic protein, regulates TRAIL-induced apoptosis through modulating c-Fos/c-FLIP pathwayInhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells.Parthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway.The transmembrane domains of TNF-related apoptosis-inducing ligand (TRAIL) receptors 1 and 2 co-regulate apoptotic signaling capacity.Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' modeTargeted expression of tumor necrosis factor-related apoptosis-inducing ligand TRAIL in skin protects mice against chemical carcinogenesis.Measuring and modeling apoptosis in single cells.Drozitumab, a human antibody to death receptor 5, has potent antitumor activity against rhabdomyosarcoma with the expression of caspase-8 predictive of response.Dynamics of the major histocompatibility complex class I processing and presentation pathway in the course of malaria parasite development in human hepatocytes: implications for vaccine development.Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapy.
P2860
Q22305521-9FD5C054-2C93-4EBB-8497-B4E7643478E6Q24292952-7DF98C79-0855-4C3B-A739-AB8E9C156C7DQ24299363-59449103-E338-4AA5-A706-F836E969C21BQ24302531-8CCACF56-2F59-4B2A-AC9D-6EDEEA2BDBE3Q24318990-C3E2ED16-4FFC-4687-B4D7-72826B840266Q24339491-E4177E11-DB3F-403B-B129-748478E64CF0Q26995349-BA5EC42D-74E1-436E-9A16-8CA318199230Q26998591-E437138F-EC81-43DE-A3CF-6027356A48E0Q27000347-B7849679-2489-4F38-A63C-67300956902EQ27684386-5BFFBA07-901A-41F2-92DB-A58A17335BADQ28067107-589C39DC-D0A1-479B-9CB8-68C2BC6F40C8Q28115758-1C133F0F-3AE5-4918-A5B4-2CAE2DBDC1DAQ28384960-8A7C2E0E-FED6-40D8-A020-5EDDC60C1027Q28391040-7001B2BF-3564-4C12-A2D0-32DD0982E853Q28478469-28BE226A-1AEB-44F2-A39D-6A5A2BE06A04Q28487858-103FAC9E-6A63-400B-BE36-878D04D3C338Q28537588-90903BEF-532A-447E-A965-7D2B73735290Q28548165-ED1310E0-92C2-47FB-A811-6D9F829C4F02Q28581865-9F95DDA6-1959-4744-95DE-EEE867375E7AQ28817910-15909864-FDDB-42C1-96F1-E5E8C3DAD560Q28833514-9C54557A-C4DC-4177-AEAF-E9C17ADA0241Q30544925-8953EFE2-63CA-448D-85AB-143AED797042Q30576902-70F5C507-A45D-415C-8D83-5C8BB1F5CCE7Q31156045-B3B9B3A3-3DAE-4683-B6C3-EB85829728C5Q33566824-09DF7559-D907-49AA-BA8A-2AB90AFEC6A9Q33688828-99DC5F1A-AD2A-418A-8FD9-F362A0D400FEQ33758166-5E044C62-E16F-49E4-BA82-BE635BC83EC5Q33869744-8AF25D36-237A-420E-A237-C8098BA88676Q34160097-B8966DF6-C962-4706-9588-97FAA5BEB9F2Q34184457-F6E40BD6-A7A9-4EE9-BEC3-3541EE9C97DEQ34364340-523CEC93-3E79-4356-AF18-7005686E6D09Q34378553-C2D34A17-21DD-4273-8D10-F7568E95FA4EQ34390877-A7280F23-0E4F-49BE-B16F-D418613A71CBQ34608366-3B5C4560-56E2-4639-8AE7-C96F44142602Q34736820-613EB9FC-149B-40B1-ADA5-197C9A8C3FE4Q34809370-A8BD2235-BE04-413C-80FF-8FCCC2B40ED8Q34921455-BCECE0BA-D06F-4BF4-839E-F769A8DAE45DQ34988055-1F4C79D9-1E2C-4CD9-9337-C1A36FC8D988Q35005560-01EA0F79-D5A8-471E-9785-091ADFFB56FDQ35063836-E2CF4F64-B536-46E4-99D6-757FF506D447
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
New insights into apoptosis signaling by Apo2L/TRAIL.
@ast
New insights into apoptosis signaling by Apo2L/TRAIL.
@en
New insights into apoptosis signaling by Apo2L/TRAIL.
@nl
type
label
New insights into apoptosis signaling by Apo2L/TRAIL.
@ast
New insights into apoptosis signaling by Apo2L/TRAIL.
@en
New insights into apoptosis signaling by Apo2L/TRAIL.
@nl
prefLabel
New insights into apoptosis signaling by Apo2L/TRAIL.
@ast
New insights into apoptosis signaling by Apo2L/TRAIL.
@en
New insights into apoptosis signaling by Apo2L/TRAIL.
@nl
P2860
P356
P1433
P1476
New insights into apoptosis signaling by Apo2L/TRAIL.
@en
P2093
A Ashkenazi
F Gonzalvez
P2860
P2888
P304
P356
10.1038/ONC.2010.221
P407
P577
2010-06-07T00:00:00Z
P5875
P6179
1043860701